If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Dr. Monika Joshi’s research focus is in the field of genitourinary tumors, particularly in the field of immunotherapy and targeted therapy.

Clinical interests

Dr. Monika Joshi developed clinical and translational expertise in genitourinary malignancies. This experience has positioned her to undertake several innovative clinical trials with multiple collaborations and national participation. She is the disease team co-leader for the genitourinary diseases group at Penn State Cancer Institute. In addition she holds regional and national leadership roles as the co-chair for the genitourinary committee for the Big Ten Cancer Research Consortium and is also as a representative for the Pennsylvania Governor's Advisory Panel on Genetics and Genomics.

Dr. Joshi has a keen interest in developing clinical trials with novel immunotherapeutic combinations and identifying predictive and prognostic biomarkers.

Professional information

Certification, Educational Commission for Foreign Medical Graduates (ECFMG), 2006

Education/Academic qualification

Fellowship, Penn State Health Milton S. Hershey Medical Center

… → 2013

Residency, UPMC Pinnacle

… → 2010

Specialist Registrar (Fellow), University Hospitals Coventry and Warwickshire NHS Trust

… → 2007

MBBS, Manipal Academy of Higher Education

… → 2001

Fingerprint Dive into the research topics where Monika Joshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

1 Citation (Scopus)

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma

Voss, M. H., Bhatt, R. S., Vogelzang, N. J., Fishman, M., Alter, R. S., Rini, B. I., Beck, J. T., Joshi, M., Hauke, R., Atkins, M. B., Burgess, E., Logan, T. F., Shaffer, D., Parikh, R., Moazzam, N., Zhang, X., Glasser, C., Sherman, M. L. & Plimack, E. R., Jul 15 2019, In : Cancer. 125, 14, p. 2400-2408 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Placebos
Disease-Free Survival
axitinib
Human ALK1-Fc fusion protein

Comics as an Educational Tool on a Clinical Clerkship

Joshi, A., Hillwig Garcia, J., Joshi, M., Lehman, E., Khan, A., Llorente, A. & Haidet, P., Jun 15 2019, In : Academic Psychiatry. 43, 3, p. 290-293 4 p.

Research output: Contribution to journalArticle

Clinical Clerkship
Students
student
Medical Education
Psychiatry

Effect of creative writing on mood in patients with cancer

Zhu, J., Hussain, M., Joshi, A., Truica, C., Nesterova, D., Collins, J., Saunders, E. F. H., Hayes, M., Drabick, J. & Joshi, M., Jan 1 2019, In : BMJ Supportive and Palliative Care.

Research output: Contribution to journalArticle

Thermometers
Emotions
Education
Neoplasms
Standard of Care
10 Citations (Scopus)

Erdafitinib in locally advanced or metastatic urothelial carcinoma

Loriot, Y., Necchi, A., Park, S. H., Garcia-Donas, J., Huddart, R., Burgess, E., Fleming, M., Rezazadeh, A., Mellado, B., Varlamov, S., Joshi, M., Duran, I., Tagawa, S. T., Zakharia, Y., Zhong, B., Stuyckens, K., Santiago-Walker, A., De Porre, P., O'Hagan, A., Avadhani, A. & 1 others, Siefker-Radtke, A. O., Jul 25 2019, In : New England Journal of Medicine. 381, 4, p. 338-348 11 p.

Research output: Contribution to journalArticle

Carcinoma
Fibroblast Growth Factor Receptors
Immunotherapy
Disease-Free Survival
Therapeutics
Papillary Carcinoma
Recurrence
Neoplasms
Proportional Hazards Models
Neoplasm Grading